Our ACPA positive rate of 51.7% was in line with earlier studies that reported a percentage of up to 55% [18-20]; however, it was substantially lower than other studies that showed a 70% positivity rate in RA patients [21]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.